Economic considerations for market access of new health technologies: A case study of pharmacogenetic testing
Research output: Contribution to conference › Paper
Standard Standard
Economic considerations for market access of new health technologies: A case study of pharmacogenetic testing. / Hughes, D.; Hughes, D.A.
2008. Paper presented at Centre for Prospective Regulation, University of York, UK.
2008. Paper presented at Centre for Prospective Regulation, University of York, UK.
Research output: Contribution to conference › Paper
HarvardHarvard
Hughes, D & Hughes, DA 2008, 'Economic considerations for market access of new health technologies: A case study of pharmacogenetic testing', Paper presented at Centre for Prospective Regulation, University of York, UK, 3/01/01.
APA
Hughes, D., & Hughes, D. A. (2008). Economic considerations for market access of new health technologies: A case study of pharmacogenetic testing. Paper presented at Centre for Prospective Regulation, University of York, UK.
CBE
Hughes D, Hughes DA. 2008. Economic considerations for market access of new health technologies: A case study of pharmacogenetic testing. Paper presented at Centre for Prospective Regulation, University of York, UK.
MLA
Hughes, D. and D.A. Hughes Economic considerations for market access of new health technologies: A case study of pharmacogenetic testing. Centre for Prospective Regulation, University of York, UK, 03 Jan 0001, Paper, 2008.
VancouverVancouver
Hughes D, Hughes DA. Economic considerations for market access of new health technologies: A case study of pharmacogenetic testing. 2008. Paper presented at Centre for Prospective Regulation, University of York, UK.
Author
RIS
TY - CONF
T1 - Economic considerations for market access of new health technologies: A case study of pharmacogenetic testing
AU - Hughes, D.
AU - Hughes, D.A.
PY - 2008/2/1
Y1 - 2008/2/1
M3 - Paper
T2 - Centre for Prospective Regulation, University of York, UK
Y2 - 3 January 0001
ER -